|
|
|
Insider
Information: |
Scangos George A |
Relationship: |
Director |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
934,251 |
|
Indirect Shares
|
3,765,803 |
|
|
Direct
Value |
$30,246,957 |
|
|
Indirect Value
|
$5,264,656 |
|
|
Total
Shares |
4,700,054 |
|
|
Total
Value |
$35,511,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
Agilent Technologies Inc |
A |
Director |
2024-05-29 |
18,578 |
2024-05-29 |
17,893 |
Premium* |
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
378 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 16
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VIR |
Vir Biotechnology, Inc. |
Director |
|
2024-02-16 |
4 |
AS |
$10.24 |
$111,386 |
D/D |
(10,878) |
157,611 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2024-02-20 |
4 |
AS |
$10.22 |
$172,385 |
D/D |
(16,872) |
140,739 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2024-02-22 |
4 |
AS |
$10.05 |
$100,737 |
D/D |
(10,028) |
130,711 |
0 |
- |
|
VIR |
Vir Biotechnology, Inc. |
Director |
|
2024-02-26 |
4 |
AS |
$11.65 |
$206,522 |
D/D |
(17,722) |
112,989 |
0 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2004-03-31 |
4 |
B |
$7.00 |
$7,000 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2007-08-31 |
4 |
B |
$2.14 |
$48,227 |
D/D |
22,188 |
23,188 |
2.39 |
- |
|
ANDS |
Anadys Pharmaceuticals In... |
Director |
|
2008-08-26 |
4 |
B |
$2.70 |
$27,000 |
D/D |
10,000 |
33,188 |
2.39 |
- |
|
EXEL |
Exelixis Inc |
President & CEO |
|
2008-10-30 |
4 |
B |
$3.20 |
$80,000 |
D/D |
25,000 |
1,174,415 |
2.81 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2011-07-14 |
4 |
D |
$104.00 |
$914,264 |
D/D |
(8,791) |
54,374 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2011-07-15 |
4 |
D |
$104.00 |
$926,744 |
D/D |
(8,911) |
66,804 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2012-02-10 |
4 |
D |
$118.14 |
$827,807 |
D/D |
(7,007) |
66,283 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2012-07-16 |
4 |
D |
$144.61 |
$2,556,560 |
D/D |
(17,679) |
67,577 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2013-02-09 |
4 |
D |
$164.44 |
$612,210 |
D/D |
(3,723) |
46,958 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2013-02-10 |
4 |
D |
$164.44 |
$1,461,872 |
D/D |
(8,890) |
56,901 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2013-07-15 |
4 |
D |
$224.33 |
$4,489,068 |
D/D |
(20,011) |
50,239 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2014-02-09 |
4 |
D |
$315.54 |
$1,530,369 |
D/D |
(4,850) |
45,464 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2014-02-10 |
4 |
D |
$315.54 |
$2,801,995 |
D/D |
(8,880) |
55,417 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2014-02-12 |
4 |
D |
$323.04 |
$1,399,732 |
D/D |
(4,333) |
57,817 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2014-07-15 |
4 |
D |
$312.00 |
$3,139,344 |
D/D |
(10,062) |
34,812 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2015-02-09 |
4 |
D |
$396.88 |
$1,960,587 |
D/D |
(4,940) |
24,315 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2015-02-10 |
4 |
D |
$395.13 |
$3,505,198 |
D/D |
(8,871) |
34,277 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2015-02-12 |
4 |
D |
$392.11 |
$4,754,334 |
D/D |
(12,125) |
47,900 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2016-02-09 |
4 |
D |
$249.99 |
$1,326,197 |
D/D |
(5,305) |
47,059 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2016-02-12 |
4 |
D |
$247.22 |
$2,920,904 |
D/D |
(11,815) |
60,335 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Executive Officer |
|
2016-02-23 |
4 |
D |
$258.99 |
$361,291 |
D/D |
(1,395) |
61,417 |
0 |
- |
|
378 Records found
|
|
Page 10 of 16 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|